UBS Group AG - HCW BIOLOGICS INC ownership

HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 15 filers reported holding HCW BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HCW BIOLOGICS INC
ValueSharesWeighting
Q3 2023$403
+1731.8%
212
+1225.0%
0.00%
Q1 2023$22
-97.0%
16
-95.8%
0.00%
Q4 2022$732
-85.4%
381
-81.5%
0.00%
Q2 2022$5,0000.0%2,056
+20.6%
0.00%
Q1 2022$5,000
-95.8%
1,705
-95.4%
0.00%
Q3 2021$119,00037,3840.00%
Other shareholders
HCW BIOLOGICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 82,600$179,2420.00%
HighTower Advisors, LLC 354,869$770,0000.00%
Focused Wealth Management, Inc 1,000$2,1700.00%
TWO SIGMA INVESTMENTS, LP 26,540$57,5920.00%
WELLS FARGO & COMPANY/MN 101$2190.00%
NORTHERN TRUST CORP 10,205$22,1450.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 131,034$284,3430.00%
STATE STREET CORP 21,446$46,5380.00%
BlackRock Inc. 49,687$107,8210.00%
View complete list of HCW BIOLOGICS INC shareholders